Skip to content
healthcare.dev

Gemfibrozil

NDC 71209-008, Gemfibrozil, tablet, from Cadila Pharmaceuticals Limited.

Product NDC
71209-008
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203266
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMFIBROZIL600 mg/1

Pharmacologic classes

PPAR alpha [CS]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]

Package NDCNDC-11Package
71209-008-037120900080360 TABLET in 1 BOTTLE (71209-008-03)
71209-008-0871209000808180 TABLET in 1 BOTTLE (71209-008-08)
71209-008-1071209000810500 TABLET in 1 BOTTLE (71209-008-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0b50849a-66b6-4e8f-9f45-5425a875d366

Use it

Look up 71209-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.